NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | -40.0% | 25,603 | -45.6% | 0.00% | – |
| Q4 2018 | $5,000 | -37.5% | 47,103 | +36.1% | 0.00% | – |
| Q3 2018 | $8,000 | 0.0% | 34,603 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | -38.5% | 34,603 | -7.7% | 0.00% | – |
| Q1 2018 | $13,000 | 0.0% | 37,503 | 0.0% | 0.00% | – |
| Q4 2017 | $13,000 | -13.3% | 37,503 | 0.0% | 0.00% | – |
| Q3 2017 | $15,000 | -31.8% | 37,503 | -12.6% | 0.00% | – |
| Q2 2017 | $22,000 | +46.7% | 42,923 | +62.1% | 0.00% | – |
| Q1 2017 | $15,000 | -11.8% | 26,472 | +0.3% | 0.00% | – |
| Q4 2016 | $17,000 | -29.2% | 26,400 | -0.7% | 0.00% | – |
| Q3 2016 | $24,000 | -44.2% | 26,580 | -67.1% | 0.00% | – |
| Q2 2016 | $43,000 | +760.0% | 80,880 | +1290.2% | 0.00% | – |
| Q1 2016 | $5,000 | -58.3% | 5,818 | -35.1% | 0.00% | – |
| Q4 2015 | $12,000 | -25.0% | 8,967 | +28.3% | 0.00% | – |
| Q3 2015 | $16,000 | -50.0% | 6,991 | -65.0% | 0.00% | – |
| Q2 2015 | $32,000 | +357.1% | 19,990 | +341.1% | 0.00% | – |
| Q1 2015 | $7,000 | +16.7% | 4,532 | +47.1% | 0.00% | – |
| Q4 2014 | $6,000 | -88.2% | 3,080 | -92.1% | 0.00% | – |
| Q3 2014 | $51,000 | -16.4% | 38,987 | -6.1% | 0.00% | – |
| Q2 2014 | $61,000 | +103.3% | 41,500 | +152.1% | 0.00% | – |
| Q1 2014 | $30,000 | -46.4% | 16,461 | -38.8% | 0.00% | – |
| Q4 2013 | $56,000 | -16.4% | 26,894 | +7.2% | 0.00% | – |
| Q3 2013 | $67,000 | -80.9% | 25,090 | -80.9% | 0.00% | – |
| Q2 2013 | $351,000 | – | 131,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|